Market Signal Briefing

SummaryMicron Technology's FY25 earnings results confirmed a sharp turnaround, an event I anticipated in April this year. Revenue hit $37.4B (+49% yoy), and gross margin expanded 17 pts to 41%.DRAM remains the growth engine: tight supply lifted ASPs by low double-digits sequentially; DRAM revenue rose 69% yoy and now represents 79% of total revenue.A new pillar for my bull case is emerging: industry-wide NAND chip shortages could improve ASPs and margins, supporting triple-digit EPS growth over the next three quarters.Despite short-term overbought risks, I remain bullish on MU for the long term, citing strong fundamentals and continued tailwinds in both HBM and NAND segments.buradaki/iStock via Getty Images

I remain bullish on Micron Technology, Inc. (NASDAQ:MU) (NEOE:MU:CA) after the company reported record FY25 results, expanding gross margins to 41%, confirming a sharp turnaround from last year's underperformance. In my last

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - VANCOUVER, BC / ACCESS Newswire / October 8, 2025 / Alaska Energy Metals Corporation (TSXV:AEMC)(OTCQB:AKEMF) ("AEMC" or the "Company") announces that, further to a price protection filed with the TSX Venture Exchange (the "TSXV") on October 6, 2025, it will proceed with a non-brokered private placement of up to 11,764,706 units of the Company (the "Units") at a price of $0.085 per Unit for aggregate gross proceeds of up to $1,000,000. Each Unit to be issued under the Offering will be comprised of one common share in the capital of the Company (a "Share") and one Share purchase warrant (a "Warrant").

The weaker Japanese yen could boost carry trades and drive demand for risk assets such as US stock futures.

US Senate Stopgap Funding Bill Vote Looms
Traders remain on edge ahead of a pivotal Senate vote that could prolong fiscal paralysis.

While the yen’s slump lifted sentiment, US stock futures saw modest gains. Uncertainty over the potential impact of the government shutdown on the US economy limited the upside. The 2018-19 shutdown shaved roughly 0.4% off the US GDP. A similar effect on the US economy in 2025 may fuel stagflation risks, potentially weighing on sentiment.

The impasse on a stopgap funding bill continued overnight, extending the government shutdown into its ninth day on Wednesday, October 8. A Senate vote is expected today, with another failed vote likely to add to the economic uncertainty.

Gold price trends reflected growing market unease, climbing 0.65% to $4,010 in morning trading. The Kobeissi Letter commented on gold and oil price trends and potential market stress, stating:

“Gold prices relative to crude oil prices have jumped to 64 points, the highest since the 2020 pandemic. The ratio has TRIPLED over the last 2 years. Excluding the 2020 pandemic drop of crude oil prices, the ratio is now at its highest level in at least 35 years. Historically, an elevated gold-to-oil ratio signaled stress in the global economy or the financial system.”

How Are US Stock Futures Moving on Yen Losses and Economic Uncertainties?
US stock futures advanced in morning trading, partially recovering the previous day’s losses. The Dow Jones E-mini rose 30 points, the Nasdaq 100 E-mini gained 37 points, and the S&P 500 E-mini advanced 7 points.

Later Wednesday, traders should closely monitor Fed speeches and the FOMC meeting minutes for clues on the Fed’s policy stance. Rising support within the Fed for multiple Fed rate cuts in October and December could boost demand for US stock futures. Conversely, renewed concerns over inflation may weigh on risk assets.

Key Technical Levels for Dow Jones, Nasdaq 100, and S&P 500
Following the morning gains, US stock futures trade above the 50-day and 200-day Exponential Moving Averages (EMAs), reaffirming a short-term bullish bias.

However, the near-term outlook hinges on the US Senate vote, Fed rhetoric, and upcoming economic data. A government reopening could expedite the release of delayed US labor market data. Key levels traders are monitoring include:

Dow Jones

Resistance: 47,000, the October 3 record high of 47,323, 47,500.
Support: 46,500, 46,000, the 50-day EMA (45,759).

-

Partnership brings advanced cloud-native virtualization and container management solutions to India’s partner ecosystem

MUMBAI, India--(BUSINESS WIRE)--Tech Data Advanced Private Limited, a TD SYNNEX company, today announced an exclusive value-added distribution (VAD) partnership with Wind River, a global leader in delivering software for the intelligent edge. The partnership will expand access to Wind River’s cloud-native solutions in India, helping partners address growing demand for modern virtualization, hyper-converged infrastructure (HCI), and container management technologies.

With more than four decades of innovation, Wind River delivers a differentiated portfolio that includes flagship products such as VxWorks®, Wind River® Cloud Platform, Wind River Linux, eLxr Pro™, and more. These solutions offer capabilities such as a single-core control plane, single-node deployment for cloud-native platforms, and node-based licensing models — features designed to simplify deployment, reduce complexity, and accelerate time-to-value.

Through Tech Data, partners will benefit not only from access to these solutions but also from solutions aggregation and technical expertise through the Tech Center of Excellence (Tech COE) and a strong partner community, which accelerate go-to-market success and solution adoption.

“Virtualization and container technologies are driving digital transformation, and our partners are looking for solutions that combine simplicity with scalability,” said Sundaresan K., Vice President and Country General Manager, Tech Data Advanced (India) Private Limited. “Through our partnership with Wind River, we are equipping our partners with proven platforms that accelerate deployment and create new revenue streams. This collaboration not only strengthens our ecosystem but also empowers partners to deliver greater business outcomes for their customers.”

“Partnering with Tech Data not only extends Wind River’s reach in India but also positions our solutions within the broader technology stacks that enterprises rely on. Tech Data’s strength lies in bringing together complementary technologies from multiple vendors, creating integrated, end-to-end solutions. This makes them a strong partner to help us provide more value to customers, accelerate modernization, and support digital transformation across the region,” said Darrell Jordan-Smith, Chief Revenue Officer, Wind River.

To learn more about Tech Data, visit www.techdata.com/in.

About Tech Data

Tech Data, a TD SYNNEX (NYSE: SNX) company, is a leading global distributor and solutions aggregator for the IT ecosystem. We’re an innovative partner helping more than 150,000 customers in 100+ countries to maximize the value of technology investments, demonstrate business outcomes and unlock growth opportunities. Headquartered in Clearwater, Florida, and Fremont, California, TD SYNNEX’s 23,000 co-workers are dedicated to uniting compelling IT products, services and solutions from 2,500+ best-in-class technology vendors. Our edge-to-cloud portfolio is anchored in some of the highest-growth technology segments including cloud, cybersecurity, big data/analytics, AI, IoT, mobility and everything as a service. TD SYNNEX is committed to serving customers and communities, and we believe we can have a positive impact on our people and our planet, intentionally acting as a respected corporate citizen. We aspire to be a diverse and inclusive employer of choice for talent across the IT ecosystem. For more information, visit www.techdata.com/in or follow us on LinkedIn and Facebook.

Safe Harbor Statement:

Statements in this news release that are "“forward-looking statements" ” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 involve known and unknown risks and uncertainties which may cause the Company’'s actual results in future periods to be materially different from any future performance that may be suggested in this release. The Company assumes no obligation to update any forward-looking statements contained in this release.

Copyright 2025 TD SYNNEX Corporation. All rights reserved. TD SYNNEX, the TD SYNNEX Logo, and all other TD SYNNEX company, product and services names and slogans are trademarks of TD SYNNEX Corporation. Other names and trademarks are the property of their respective owners.

More News From Tech Data Advanced Private Limited

Back to Newsroom

Anthony Marino
President, CEO & Non-Independent Director

Hello. I'm Tony Marino, President and CEO of Tenaz Energy. I'll cover a PowerPoint describing our GEMS acquisition. I ask you to please first note the advisories we have at the beginning and the end of the presentation. We'll start with a brief corporate overview that will incorporate a couple of the aspects of GEMS.

First of all, the strategic model of the company remains the same, focused on acquisitions in the overseas market. Current asset base is a significant production foothold in Netherlands, making us today, we believe, the largest producer in Netherlands, except for the state company, EBN, and we continue to have our Canadian oil growth project. Two major transactions closed this year, NAM Offshore or NOBV, now called TEN within Tenaz , which we closed at the beginning of May. And the acquisition we announced today, the nonoperated interest in the GEMS project, which was a signed and closed transaction executed earlier today.

Market cap before the transaction, about CAD 575 million. After the transaction, we'll have a little bit over $400 million in debt. That's up from $100 million prior to the deal with that $100 million, including the estimate that we have made for the earn-out on the NOBV transaction. Pro forma production and by that, we mean had we owned both the GEMS and the NOBV assets for an entire year of 2025 would be 16,200 BOE/D. We'll show you our new guidance number at the end of the presentation. And our drilling and development CapEx estimated for the year, CAD 100 million to CAD 110 million. This only counts CapEx after the dates of closing of the -- each of these transactions and little change -- no change in the

Ethereum (ETH) is increasingly becoming a cornerstone for institutional investors and corporate treasury strategies. Recent data shows that the combined holdings of Ethereum treasury firms and spot ETFs have surged to 12.48 million ETH, representing 10.31% of Ethereum's total supply.

Journalist

Posted: October 8, 2025

Key Takeaways
What is driving BNB’s recent rally to record highs?
BNB’s rally was fueled by expanding on-chain activity and real-world adoption following Chainlink’s data integration.

Can BNB maintain its bullish momentum after the recent breakout?
Strong technical indicators and improving market sentiment suggest that BNB’s uptrend remains firmly supported.

Binance Coin [BNB] reached a new all-time high above $1,200, fueled by a remarkable surge in on-chain activity across the Binance Smart Chain [BSC]. 

Daily transactions ranged between 10 and 17 million, marking one of the most sustained growth periods in the network’s history.

This steady expansion signaled genuine user adoption, showing that the rally was driven by more than speculation.

Chainlink integration propels BNB toward utility
BNB Chain’s adoption of Chainlink’s data standard has introduced official U.S. economic data—such as GDP and the PCE Price Index—onto the blockchain. 

This move bridged macroeconomic data with blockchain applications, creating new opportunities for DeFi, prediction markets, and risk management.

It also enhanced BNB Chain’s credibility and positioned it as a key player in blockchain-based economic data.

The integration strengthened long-term investor confidence, showing BNB’s expanding role beyond trading speculation.

Will BNB bulls maintain control above support levels?
BNB’s technical outlook remained strongly bullish as the altcoin continued to trade above the $1,240 support zone.

In the 4-hour chart below, we could observe a clear ascending structure supported by strong buying momentum. 

According to the DMI indicator, the +DI remained well above the –DI line, while the ADX at 57 reflected a robust uptrend with strong directional momentum. 

If this momentum holds, a move toward the $1,360 resistance zone appears likely in the short term.

Source: TradingView

Rising optimism in sentiment and social buzz for BNB
Santiment data showed Binance Coin’s Social Dominance climbing to 2.67%, its highest in months, while Weighted Sentiment hit 1.81. Both indicated renewed optimism among traders.

The rise in engagement aligned with the Chainlink integration and BSC’s high activity, reinforcing the bullish bias.

Historically, similar sentiment surges have preceded strong rallies, suggesting traders expect BNB’s momentum to continue.

Can network growth sustain this rally?
BNB’s rally shows strength, firmly backed by organic network expansion and real-world utility growth.

The surge in transaction volumes, along with Chainlink’s integration of official U.S. economic data, confirms that this uptrend rests on solid fundamentals.

Unlike earlier speculative spikes, the current uptrend was tied to organic growth and developer participation.

This suggests BNB’s price strength could persist, reflecting a shift toward sustained, utility-driven demand.

Monetary Authority of Singapore spokesperson tells CoinDesk that entities not regulated as financial institutions are not subject to sanctions measures.
Oct 8, 2025, 2:05 a.m.

Good Morning, Asia. Here's what's making news in the markets:Welcome to Asia Morning Briefing, a daily summary of top stories during U.S. hours and an overview of market moves and analysis. For a detailed overview of U.S. markets, see CoinDesk's Crypto Daybook Americas.

A7A5’s appearance at the recent Token2049 conference wasn’t in contravention of Singaporean law, despite being backed by a sanctioned Russian bank, highlighting the limits of the city-state’s sanctions regime, which applies only to licensed financial firms.

A7A5's ruble-based stablecoin is backed by Russia’s state-owned Promsvyazbank (PSB), an entity sanctioned by the Monetary Authority of Singapore (MAS) as well as financial authorities in the U.S., U.K., and most Western jurisdictions. Bloomberg recently reported that the E.U., as a bloc, is considering sanctions against A7A5 too.

STORY CONTINUES BELOW

Indeed, an audit prepared for Old Vector LLC, the parent company behind A7A5, warns of possible "redemption and regulatory issues" regarding use of the tokens considering the breadth of the sanctions.

Given A7A5 was a sponsor at Token2049, complete with booths and branded massage rooms, one has to wonder if this contravened Singaporean rules given the exchange of funds.

The answer, according to MAS, is no.

"Singapore financial institutions (FI) are not permitted to facilitate transactions (whether directly or indirectly) for designated persons in contravention of our financial measures," a MAS Spokesperson told CoinDesk in an email. "An entity that is not an FI regulated by the MAS is not subject to the financial measures."

Under Singapore’s sanctions framework, financial measures targeting Russia’s Promsvyazbank and related entities bind banks, insurers, capital-markets intermediaries, and digital payment token providers.

But, according to MAS' own guidance, non-financial companies and individuals are only obligated to comply with United Nations-mandated sanctions, which have never been applied to Russia as the country would veto them as a member of the U.N. security council.

Furthermore, Token2049 is organized by Hong Kong registered BOB Group. Hong Kong, as part of China, does not have any financial sanctions on Russia which makes recieving funds from A7A5 legal in the territory.

Singapore's sanctions are a bit different from what's been imposed in the U.S. where the company behind A7A5 is Specially Designated National (SDN) under U.S. Treasury’s Office of Foreign Assets Control (OFAC) meaning U.S. persons are prohibited from interacting with them in any way.

It may seem like an edge case, but Foundation for Global Political Exchange v. U.S. Treasury shows just how far those restrictions can go.

OFAC initially denied the Foundation for Global Political Exchange, a U.S. nonprofit, permission to host members of Hezbollah – understandably sanctioned individuals – at a forum they organized in Beiruit about peace in the middle east, ruling that simply offering a platform or audience constituted a prohibited service under U.S. sanctions law. Only after a first amendment challenge did OFAC reverse its position, narrowly allowing participation under strict conditions: no payments, no lodging, no coordination, and no affiliation with the event’s host.

By that standard, even in the U.S., hosting A7A5 could be legal if no money or material support changed hands. In Singapore, where sanctions bind financial institutions but not conference organizers, it’s an even easier call. Washington regulates who you can pay; Singapore regulates who can move the money.

Somewhere between those two philosophies – and one Hong Kong crypto wallet – A7A5 found a perfectly legal booth and massage room.

Market MovementBTC: Bitcoin fell to around $122,000, down 3% from record highs, as analysts warned the crypto rally had become overheated following the year’s largest ETF inflows and leveraged positioning, with Deribit projecting a possible pullback to $118,000–$120,000 before another run toward $130,000

ETH: Ethereum is trading around $4,479, down 4.4%, as traders lock in profits following recent gains and rotate out of ETH into other assets, pressuring prices after a strong rally.

Gold: Gold surged past $4,000 for the first time as investors flocked to safe havens amid a weaker dollar, Fed rate cuts, and geopolitical uncertainty, with central banks and retail buyers driving demand; Goldman Sachs lifted its 2026 forecast to $4,900, though Bank of America warned the rally may be overextended.

Nikkei 225: Asia-Pacific markets traded mixed Wednesday, while Japan’s Nikkei 225 hovered around 48,120 — buoyed by optimism over pro-growth policies under new LDP leadership and a tech-fueled global rally, even as concerns about stimulus durability and valuation risks linger.

Elsewhere in Crypto:Trump Memecoin Issuer Zanker Is Planning Digital Asset Treasury Company (Bloomberg)Gemini stock projected for 25% upside driven by crypto reward card ‘flywheel’ and EU license (The Block)CleanCore's Dogecoin Treasury Tops 710M Tokens, Booking $20M+ Gain (CoinDesk)More For You

Total Crypto Trading Volume Hits Yearly High of $9.72T

Sep 9, 2025

Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025

What to know:

Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025Gate exchange emerged as major player with 98.9% volume surge to $746 billion, overtaking Bitget to become fourth-largest platformOpen interest across centralized derivatives exchanges rose 4.92% to $187 billionView Full Report

More For You

XRP Drops to $2.90 Support as Bullish Crypto Bets Rack up $500M Liquidations

20 minutes ago

Traders are watching if XRP can hold the $2.85–$2.87 support band amid broader market pressures.

What to know:

XRP fell nearly 4% as institutional selling forced a breakdown from the $2.99 resistance zone.Ripple's push for a U.S. national banking charter faces scrutiny ahead of the Oct. 7 OCC deadline.Traders are watching if XRP can hold the $2.85–$2.87 support band amid broader market pressures.Read full story

Leading cryptocurrencies slumped alongside markets on Tuesday, while gold surged to fresh highs, as the U.S. government shutdown entered its seventh day.

CryptocurrencyGains +/-Price (Recorded at 9:30 p.m. ET)Bitcoin (CRYPTO: BTC)-2.17%$122,010.53Ethereum (CRYPTO: ETH)
               -4.13%$4,486.78XRP (CRYPTO: XRP)                         -3.73%$2.87Solana (CRYPTO: SOL)                         -4.09%$222.04Dogecoin (CRYPTO: DOGE)                         -5.65%$0.2498Market Cools DownBitcoin fell below $121,000, ending a week-long rally that had sent it to record highs. Trading volume surged 15% in the last 24 hours, suggesting high selling pressure.

Similarly, Ethereum retreated from the mid $4,700s to below $4,500, while volumes jumped 60%. XRP and Solana also recorded sharp declines.

In the past 24 hours, 167,851 traders were liquidated, with total cryptocurrency liquidations at $621.29 million, according to Coinglass. Nearly $470 million in bullish longs were wiped out.

Bitcoin’s open interest fell 3.33% to $90.81 billion, while more than 50% of Binance futures traders remained bearish on the asset, according to the Long/Short ratio.

The market’s "Greed" sentiment weakened, according to the Crypto Fear & Greed Index.

Top Gainers (24 Hours) 

Cryptocurrency (Market Cap>$1 B)Gains +/-Price (Recorded at 9:30 p.m. ET)PancakeSwap (CAKE)     +14.15%$4.29DeXe (DEXE)    
               +10.92%$13.01slisBNBx (slisBNBx )          +8.66%$1,314.36The global cryptocurrency market capitalization stood at $4.16 trillion, contracting 2.58% in the last 24 hours.

Stocks Fall, Gold Hits Record HighStocks retreated from record highs on Tuesday. The S&P 500 slid 0.38% to close at 6,714.59, snapping a 7-day winning streak. The tech-heavy Nasdaq Composite dipped 0.67% to end at 22,788.36. The Dow Jones Industrial Average dropped 91.99 points, or 0.2%, to end at 46,602.98.

The tech stocks were pressured as shares of Oracle Corp. (NASDAQ:ORCL) fell following reports suggesting that the company is facing financial challenges in renting out Nvidia Corp. (NASDAQ:NVDA) chips.

Meanwhile, gold prices rose to a new high of $4,000 per ounce on Tuesday. The federal government shutdown entered its seventh day.

Risk-On Switch Incoming?Widely followed cryptocurrency analyst and trader Michaël van de Poppe was optimistic about new all-time highs for Ethereum, noting a potential reversal in the ETH/BTC ratio after a normal correction.

Van De Poppe also linked it to gold's "insanely parabolic" trajectory, predicting a "big risk-on switch" once the precious metal falls.

Ali Martinez, another well-known trader, said that $4,000–$4,800 has been a "danger zone" for ETH since 2021, with each touch resulting in a correction.

Photo Courtesy: OMG_Studio on Shutterstock.com

Read Next:    

NYSE Parent ICE Stock Surges After Reported $2 Billion Polymarket Investment
Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

ETF analyst Eric Balchunas says Canary Capital's filings for spot Litecoin and HBAR funds are seemingly finalized, but the government shutdown will delay their launch.

TL;DR

CleanCore Solutions now holds over 710 million DOGE in its corporate treasury, with more than $20 million in unrealized gains.
The company raised $175 million through a private placement.
Its strategy focuses on disciplined accumulation, regulated liquidity, and professional governance to establish DOGE as a long-term corporate asset.

CleanCore Solutions, a New York Stock Exchange-listed company under the ticker ZONE, is building one of the largest corporate Dogecoin treasuries, which has just surpassed 710 million tokens on its balance sheet.

The firm began purchasing DOGE on September 5 after raising $175 million in a private placement and already holds more than $20 million in unrealized gains. Its target is to reach 1 billion DOGE. The initiative is part of a broader strategy supported by the Dogecoin Foundation and coordinated through its corporate arm, House of Doge.

The accumulation program is executed in phases through a disciplined capital deployment framework. According to the company, this approach aims to balance market value growth with balance sheet stability, prioritizing transparency and operational efficiency. CleanCore maintains sufficient liquidity to continue strengthening its position, supported by a partnership with Bitstamp by Robinhood, which serves as a fully regulated platform for executing and safeguarding token purchases.

CleanCore: Transforming the Nature of DOGE
CEO Clayton Adams explained that the company’s treasury strategy aligns with the long-term vision of the Dogecoin Foundation and internal shareholders, who view the token’s growing utility as the key driver of global adoption. According to Adams, CleanCore’s focus goes beyond accumulation—it seeks to build a sustained relationship between market capitalization and the company’s adjusted net asset value (mNAV).

The shares issued in the recent private placement are currently restricted or locked up, and the company is working with the SEC to register them while monitoring short interest in its stock. Meanwhile, House of Doge continues developing applications aimed at positioning Dogecoin as both a transactional currency and a long-term reserve asset, which could strengthen the token’s structural demand.

CleanCore is working to institutionalize DOGE in the corporate arena by combining professional governance, gradual accumulation, and regulated liquidity

US Government Shutdown Delays XRP-Spot ETF Greenlight
Amid economic uncertainty, the ongoing US government shutdown could also delay the SEC approval of S-1s for XRP-spot ETFs.

Overnight, the US Senate adjourned without voting on a stopgap funding bill, needed to reopen the government. Entering an eighth day on Wednesday, October 8, the government shutdown could mean XRP-spot ETFs will launch after their original final decision deadlines.

The launch of XRP-spot ETFs remains crucial, with analysts expecting a surge in Main Street demand, given XRP’s real-world utility.

With XRP-spot ETFs on hold amid the shutdown, XRP lost its coveted #3 ranking by market cap, dropping to #5. Binance Coin (BNB) and Tether (USDT) flipped the token.

However, the negative sentiment could be short-lived. Santiment, a market intelligence platform, commented on the recent surge in fear, uncertainty, and doubt (FUD) toward XRP, stating:

“XRP is seeing its highest level of retail FUD since Trump’s tariffs were announced 6 months ago. There have been more bearish comments than bullish for 2 of the past 3 days, which is generally a promising buy signal. Markets move opposite to small trader expectations.”

Senate Vote Key to Restoring Market Confidence
Turning to the Wednesday, October 8, session, the US Senate is expected to vote on stopgap funding bills. XRP could rebound if the Senate reaches the 60 votes required to pass a bill. SEC staff would return to work after the bill passes, raising expectations of an XRP-spot ETF launch.

An XRP-spot ETF market could be crucial for XRP’s price trajectory, considering the success of the US BTC-spot ETF market.

Nate Geraci, President of NovaDius Wealth Management, commented on BlackRock’s (BLK) iShares Bitcoin Trust (IBIT), stating:

“iShares Bitcoin ETF on verge of surpassing $100bil AUM… World’s largest ETF, Vanguard S&P ETF, took 2,000+ days to hit that mark. IBIT about to do it in< 450 days. Easily fastest ever. First ETF launched in 1993, so we’re talking 30+ yrs of history.”

Market Structure Bill on Ice
While market focus remains on the XRP-spot ETF filings, potential delays to the Market Structure Bill’s progress in the Senate pose another headwind for XRP. The bill, which aims to clarify the classification of crypto assets, remains stalled in the Senate.

The government shutdown could delay a Senate vote on the Market Structure Bill into 2026. Crypto-friendly legislation is expected to be crucial in drawing retail investors. XRP remains exposed to legislative developments, given the long-lasting SEC vs. Ripple case, which ended in August.

XRP soared 14.69% on July 17 as investors reacted to the US House of Representatives passing the bill to the Senate. For context, the total crypto market cap rose just 1.78%.

Price Action & Technical Analysis: Can Bulls Reclaim $3?
XRP tumbled 4.56% on Tuesday, October 7, reversing the previous day’s 0.68% gain, to close at $2.8545. The token underperformed the broader market, which fell 2.8%, but held above crucial support levels.

Traders are watching the following technical levels:

Support: $2.8, $2.5.
Resistance: $3, $3.1, $3.3, $3.66 (all-time high).

Catalysts & Scenarios
In the coming sessions, several key factors could drive near-term price trends:

US Senate votes on a stopgap funding bill.
XRP ETF demand, crypto-spot ETFs (delays or launches), and BlackRock’s stance on an iShares XRP Trust.
Blue-chip companies’ positions on XRP as a treasury reserve asset.
Regulatory milestones: Ripple’s application for a US-chartered bank license, the Market Structure Bill, and SWIFT-related headlines would likely influence near-term price trends.

Bearish Scenario

GDLC, BITW, and XRPR ETFs face weak demand, and BlackRock dismisses plans for an XRP-spot ETF.
US Senate vote fails to reach 60, extending the government shutdown and delaying XRP-spot ETF approvals.
Lawmakers push back against crypto-friendly regulations, such as the Market Structure Bill.
Blue-chip companies dismiss XRP as a treasury reserve asset.
OCC delays or rejects Ripple’s US-chartered bank license.
SWIFT retains global remittance market share, limiting Ripple’s market access.

These bearish scenarios could drag XRP below $2.8, potentially exposing the $2.5 support level.

Bullish Scenario

US Senate passes stopgap funding bill.
BITW, GDLC, and XRPR register strong demand.
BlackRock files an S-1 for an iShares XRP Trust, and the SEC approves XRP-spot ETFs.
Blue-chip companies acquire XRP for treasury purposes, and more payment platforms adopt Ripple technology.
Ripple secures a US-chartered bank license, and the Senate passes the Market Structure Bill.
SWIFT loses market share in the global remittance business to Ripple.

These bullish scenarios could send XRP above $3, bringing $3.1 into play. A sustained move through $3.1 could pave the way toward $3.3 and the all-time high of $3.66.

In stark contrast to the broader resurgence in the cryptocurrency market, where many assets are approaching or exceeding record highs, the XRP price finds itself in a precarious position. The altcoin has consistently failed to breach its nearest resistance level at $3, resulting in a retracement to crucial support levels that are vital for preventing a significant correction and further declines.

Trump meme coin issuer Fight Fight Fight LLC seeks at least $200m to fund a digital asset treasury after the token's plunge.

Sen. Cynthia Lummis (R-Wyo.) piqued the curiosity of cryptocurrency enthusiasts Tuesday after stating that funding for a Strategic Bitcoin (CRYPTO: BTC) Reserve can start “anytime.”

Legislating Is A Slog, Says LummisIn an X post, Lummis said that efforts are underway to work toward the passage of a BITCOIN Act,  a bill proposing the acquisition of 1 million BTC over five years, with a 20-year holding period,  leveraging budget-neutral strategies like Federal Reserve remittances and gold certificate revaluations.

“Legislating is a slog, and we continue to work toward passage, but thanks to President Trump, the acquisition of funds for an SBR can start anytime,” Lummis said.

See Also: Ray Dalio Doubts Any Central Bank Would Take On Bitcoin As Reserve Currency Despite Many Seeing It As Alternative Money: ‘There’s No Privacy’

Support For Gold Revaluation To Fund SBRLummis responded to Jeff Park, Chief Investment Officer at ProCap Financial, who, during a recent interview, pushed for using paper gains on U.S. gold holdings to buy Bitcoin.

“The thing that is really interesting is what if we actually do find a way to find a funding-based liquidity on the trillion dollars of gold and buy Bitcoin,” Park said. “And a trillion dollars of Bitcoin is actually hugely impactful for the Bitcoin market.”

The market value of America’s gold reserves surpassed $1 trillion last month, far above the official $11 billion valuation based on a statutory price of $42.22 an ounce set in 1973.

Will The Government Buy BTC?Little has come from the executive side since President Donald Trump signed an order to establish a Bitcoin reserve earlier this year. Trump's crypto advisor, David Sacks, said in May that the path to acquiring Bitcoin was ready, and it’s just a matter of getting the Commerce Department and the Treasury Department “excited.”

Interestingly, Treasury Secretary Scott Bessent stated in August that the government would not buy additional BTC and expressed “doubt” about revaluing gold, but later signaled that budget‑neutral options to expand the reserve were being considered.

The U.S. government holds 198,021 BTC, worth approximately $24.17 billion, according to on-chain analytics firm Arkham, with the majority seized from criminal and civil forfeiture proceedings.

Price Action: At the time of writing, BTC was trading at $122,083, down 1.96% over the last 24 hours, according to data from Benzinga Pro. 

Read Next: 

Bitcoin Targets $130,000—And This ‘Supertrend’ Indicator Just Flipped Bullish
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Photo Courtesy: Victor Sanchez G on Shutterstock.com

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Record $1.18B ETF inflows boost investor optimism — Bitcoin price prediction targets $160K as institutional demand accelerates.

In brief
Market breadth has weakened as capital concentrates in high-liquidity, high-certainty assets like Bitcoin and Ethereum.
Experts cite institutional ETF flows and a loss of patience with purely narrative-driven altcoins.
Any future altcoin rally is expected to be highly selective, favoring tokens with real-world utility.
Bitcoin and Ethereum continue to capture investor interest, while the broader altcoin market struggles to keep pace, creating a divergence that experts believe is a result of the markets maturing. 

While major assets like Ethereum, XRP, and Solana have notched double-digit year-to-date gains, the performance across the rest of the top 10 cryptocurrencies by market capitalization has been lackluster. 

With the exception of BNB, which has reached multiple record highs this year, other tokens like Chainlink, Cardano, Sui, and Dogecoin have seen performance ranging from single-digit gains to double-digit losses for the year, according to CoinGecko data.

The percentage of coins trading above their 200-day moving average, often a barometer for an asset’s bullish or bearish slant, has fallen to approximately 55%, a notable decline from this year's peak of 78% recorded on September 13, according to data from MacroMicro. 

“Capital naturally prefers assets with high liquidity, clear narratives, and strong certainty,” Jeffrey Ding, chief analyst at HashKey Group, told Decrypt. 

He explained that a structurally divided market is inevitable under current macroeconomic conditions, with capital favoring top assets like Bitcoin and Ethereum, driven primarily by institutional flows via ETFs and corporate treasuries.

Ding explained that many altcoins are being left behind because they have failed to connect with new market narratives, citing examples of AI, RWA, and decentralized exchange narratives that have failed to gain traction.

"The market is losing patience with high-valuation, low-circulating-supply tokens lacking clear use cases,” he added.

“It's a sign that the industry is maturing,” Peter Chung, Head of Research at Presto Research, told Decrypt. “Market participants have learned over the years how to evaluate projects based on their merits and differentiate winners from losers.”

He attributes this shift to the changing composition of market participants. 

“With increasing institutional participation, the days of retail investors aping in and out of particular sectors just based on 'vibes' are mostly behind us,” Chung explained. 

“The retail investors are, of course, still there doing their things, but their overall impact on the market is much less, and is overwhelmed by the institutional flow, which is much larger and disciplined.”

Chung noted that while retail-driven rallies still occur in specific niches—citing ZCash as a recent example—these are now "pockets of strength" rather than market-wide trends.

Zcash, a privacy coin, has rallied 140% in the past two weeks to $134, per CoinGecko data, yet it remains 95.9% below its all-time high of $3,191. The token's rise comes after it received endorsements from multiple prominent investors in both crypto and traditional finance, Decrypt previously reported.

Looking ahead, Ding expects a change, but not a return to a broad-based altcoin boom.

"The current stagnation does not mean altcoins will be absent this cycle—rather, they may awaken when Bitcoin and Ethereum enter a consolidation phase," he said. 

However, Ding emphasized that any rally will be "highly selective," favoring tokens "anchored to real-world utility and value creation, not mere storytelling."

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

The Korean carmaker is betting big on the U.S., even as new trade and immigration policies pose hurdles

NEW YORK CITY and NEW ORLEANS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 13, 2025 to file lead plaintiff applications in a securities class action lawsuit against KinderCare Learning Companies, Inc. (NYSE: KLC), if they purchased the Company’s shares pursuant and/or traceable to the Company’s October 2024 initial public offering (the “IPO”). This action is pending in the United States District Court for the District of Oregon.

What You May Do

If you purchased shares of KinderCare as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit http://ksfcounsel.com/cases/nyse-klc/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 13, 2025.

About the Lawsuit

KinderCare and certain of its executives and others are charged with failing to disclose material information in its IPO Registration Statement and Prospectus (collectively, the “Offering Documents”), violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) numerous incidents of child abuse, neglect, and harm had occurred at KinderCare facilities; (ii) the Company did not provide the “highest quality care possible” at its facilities, and, indeed, in numerous instances had failed to provide even basic care, meet minimum standards in the child care industry, or comply with the laws and regulations governing the care of children; and (iii) as a result, the Company was exposed to a material, undisclosed risk of lawsuits, adverse regulatory action, negative publicity, reputational damage, and business loss.

The case is Gollapalli v. KinderCare Learning Companies, Inc., No. 25-cv-01424.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Matachewan Consolidated Mines, Limited (“Matachewan” or the “Company”) (TSX-V: MCM.A-X) today announces that, from March 17, 2025 to August 7, 2025, it sold an aggregate of 91,530 common shares of Kinross Gold Corporation for aggregate consideration of $2,049,194. The Company obtained the written consent of a majority of its shareholders for the disposition, in accordance with TSXV Policy 5.3.

NEW YORK and NEW ORLEANS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 14, 2025 to file lead plaintiff applications in a securities class action lawsuit against Fluor Corporation (NYSE: FLR), if they purchased or otherwise acquired the Company’s securities between February 18, 2025 and July 31, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Texas.

What You May Do

If you purchased securities of Fluor and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-flr/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 14, 2025.

About the Lawsuit

Fluor and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On August 1, 2025, the Company announced its financial results for the second quarter of 2025, disclosing a Q2 non-GAAP EPS of $0.43, missing consensus estimates by $0.13, and revenue of $3.98 billion, representing a 5.9% year-over-year decline and missing consensus estimates by $570 million due to growing costs in multiple infrastructure projects due to subcontractor design errors, price increases, and scheduling delays, as well as reduced capital spending by customers. The Company also disclosed a negatively revised financial outlook for FY 2025, guiding to adjusted EBITDA of $475 million to $525 million, down significantly from Defendants' prior guidance of $575 million to $675 million, and adjusted EPS of $1.95 per share to $2.15 per share, down significantly from Defendants' prior guidance of $2.25 per share to $2.75 per share.

On this news, the price of Fluor’s shares fell $15.35 per share, or 27.04%, to close at $41.42 per share on August 1, 2025.  

The case is Maglione v. Fluor Corporation, et al., No. 25-cv-02496.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Analyst’s Disclosure:I/we have a beneficial long position in the shares of VGT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

NEW YORK CITY and NEW ORLEANS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquired the Company’s securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

What You May Do

If you purchased securities of Cytokinetics and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-cytk/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 17, 2025.

About the Lawsuit

Cytokinetics and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On March 10, 2025, the Company disclosed that the U.S. Food and Drug Administration (“FDA”) had decided not to convene an advisory committee meeting to review the Company’s New Drug Application (“NDA”) for its aficamten product. Then, on May 6, 2025, the Company disclosed that it had held multiple pre-NDA meetings with the FDA discussing safety monitoring and risk mitigation but chose to submit the NDA without a Risk Evaluation and Mitigation Strategy, instead relying on labeling and voluntary education materials.

On this news, the price of Cytokinetics’ shares fell, closing at $33.04 per share on May 7, 2025.  

The case is Seidman v. Cytokinetics, Incorporated, et al., No. 25-cv-07923.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

October 07, 2025 21:29 ET

 | Source:

Esperion Therapeutics, Inc.

ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C), today announced the pricing of an underwritten public offering of 30,000,000 shares of its common stock at a public offering price of $2.50 per share. In addition, Esperion has granted the underwriters a 30-day option to purchase up to an additional 4,500,000 shares of its common stock. The gross proceeds to Esperion from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $75.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. All of the shares of common stock in the offering are to be sold by Esperion. The offering is expected to close on or about October 9, 2025, subject to satisfaction of customary closing conditions.

Piper Sandler & Co. and Cantor Fitzgerald & Co. are acting as joint book-running managers for the offering. Citizens JMP Securities, LLC, H.C. Wainwright & Co., LLC and Needham & Company, LLC are acting as co-managers for the offering.

The shares of common stock are being offered by Esperion pursuant to an effective shelf registration statement that was previously filed with the U.S. Securities and Exchange Commission (SEC) on April 18, 2025 and declared effective by the SEC on April 29, 2025 (File No. 333-286631). The offering is being made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement relating to and describing the terms of the offering was filed with the SEC and is available on the SEC’s website at www.sec.gov.

When available, copies of the final prospectus supplement relating to and describing the final terms of the offering may also be obtained from Piper Sandler & Co., Attention: Prospectus Department, 350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401 or by email at [email protected]; or Cantor Fitzgerald & Co., Attention: Equity Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022, or by email at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Esperion Therapeutics

Esperion is a commercial stage biopharmaceutical company focused on bringing new medicines to market that address unmet needs of patients and healthcare professionals. Esperion developed and is commercializing the only U.S. Food and Drug Administration (FDA) approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease and are struggling with elevated low density lipoprotein cholesterol (LDL-C). These medications are supported by the nearly 14,000 patient CLEAR Cardiovascular Outcomes Trial. Esperion continues to build on its success with its next generation program which is focused on developing ATP citrate lyase inhibitors (ACLYi). New insights into the structure and function of ACLYi fully enables rational drug design and the opportunity to develop highly potent and specific inhibitors with allosteric mechanisms.

Esperion continues to evolve into a leading global biopharmaceutical company through commercial execution, international partnerships and collaborations and advancement of its pre-clinical pipeline.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation implied and express statements about Esperion’s beliefs and expectations regarding: the timing and closing of the public offering. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “suggest,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are based on management’s current expectations and beliefs and involve risks, uncertainties and other factors that may cause actual events or results to differ materially from those projected, including, without limitation, fluctuations in Esperion’s stock price, changes in market conditions, and satisfaction of customary closing conditions related to the offering. These and other risks and uncertainties are described in greater detail in Esperion’s filings with the SEC, including in its Annual Report on Form 10-K for the year ended December 31, 2024 and in its subsequent filings with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Esperion disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.

Esperion Contact Information:

Investors:
Alina Venezia
[email protected]
(734) 887-3903

Media:
Tiffany Aldrich
[email protected]
(616) 443-8438

Item 1 of 2 The logo of the Organisation of the Petroleum Exporting Countries (OPEC) is seen at OPEC's headquarters in Vienna, Austria December 5, 2018. REUTERS/Leonhard Foeger

[1/2]The logo of the Organisation of the Petroleum Exporting Countries (OPEC) is seen at OPEC's headquarters in Vienna, Austria December 5, 2018. REUTERS/Leonhard Foeger Purchase Licensing Rights, opens new tab

SINGAPORE, Oct 8 (Reuters) - Oil prices edged higher in early trade on Wednesday as markets started to brush off oversupply fear for the time being, having digested a decision by OPEC+ to restrain November production increases.

Brent crude futures was up 40 cents, or 0.6%, to $65.85 a barrel by 0045 GMT. U.S. West Texas Intermediate crude climbed 44 cents, or 0.7%, to $62.17.

Sign up here.

The benchmarks settled broadly flat in the previous session as investors weighed signs of a supply glut against a smaller-than-expected increase to November output from the Organization of the Petroleum Exporting Countries and affiliates.

OPEC+ had opted for a rise of 137,000 barrels a day, the lowest amount among options the group discussed at the weekend.

"Until the physical market shows signs of softening via rising inventories, investors are likely to discount the impact of the production increases," ANZ analysts said on Wednesday.

Price gains are however capped as fear of Russian supply disruption eased, with crude oil shipments holding close to a 16-month high over the past four weeks, the analysts said.

Investors are also on the look out for U.S. inventory trends from the Energy Information Administration later on Wednesday.

U.S. crude stocks rose by 2.78 million barrels in the week ended October 3, sources said on Tuesday citing American Petroleum Institute figures.

Conversely, gasoline and distillate inventories fell, the sources said, citing API data.

Meanwhile, U.S. oil production is likely to set a larger record this year than previously expected, the EIA said on Tuesday.

Reporting by Jeslyn Lerh; Editing by Christopher Cushing

Our Standards: The Thomson Reuters Trust Principles., opens new tab